RA Capital Management, L.P. 13D and 13G filings for Connect Biopharma Holdings Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-27 4:19 pm Sale |
2024-02-23 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 0 0.000% |
-3,062,871 (Position Closed) |
Filing |
| 2023-12-20 4:30 pm Sale |
2023-12-18 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 3,062,871 5.600% |
-2,061,438 (-40.23%) |
Filing |
| 2023-12-14 4:30 pm Sale |
2023-12-12 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 5,124,309 9.300% |
-830,702 (-13.95%) |
Filing |
| 2023-12-04 5:20 pm Sale |
2023-11-30 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 5,955,011 10.800% |
-1,035,992 (-14.82%) |
Filing |
| 2021-06-07 5:12 pm Purchase |
2021-06-04 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 6,991,003 12.200% |
350,586 (+5.28%) |
Filing |
| 2021-03-29 4:30 pm Purchase |
2021-03-19 | 13D | Connect Biopharma Holdings Limited CNTB |
RA Capital Management, L.P. | 6,640,417 11.500% |
6,640,417 (New Position) |
Filing |